KDL Biotech Ltd. - Research Center
532291 KOPDRUGS Group (Z) BSE data
Results
|
Quarterly
|
Statement
|
|
More
|
|
Quarterly results in brief
(Rs crore)
|
Dec' 14 |
Jun' 13 |
Mar' 13 |
Sep' 12 |
Jun' 12 |
Sales |
- |
0.99 |
5.13 |
6.57 |
4.84 |
Operating profit |
-0.34 |
-1.24 |
-0.28 |
-0.41 |
-1.40 |
Interest |
1.27 |
1.71 |
1.72 |
1.73 |
1.69 |
Gross profit |
-1.59 |
-2.88 |
-1.89 |
-2.05 |
-3.01 |
EPS (Rs) |
-1.38 |
-1.91 |
-1.50 |
-1.58 |
-1.97 |
Quarterly
results in details
|
Dec' 14 |
Jun' 13 |
Mar' 13 |
Sep' 12 |
Jun' 12 |
Other income |
0.02 |
0.07 |
0.12 |
0.08 |
0.08 |
Stock adjustment |
- |
- |
- |
- |
- |
Raw material |
- |
0.05 |
0.10 |
0.56 |
0.04 |
Power and fuel |
- |
- |
- |
- |
- |
Employee expenses |
0.05 |
1.20 |
2.23 |
2.63 |
2.40 |
Excise |
- |
- |
- |
- |
- |
Admin and selling expenses |
- |
- |
- |
- |
- |
Research and development expenses |
- |
- |
- |
- |
- |
Expenses capitalised |
- |
- |
- |
- |
- |
Other expenses |
0.29 |
0.97 |
3.07 |
3.79 |
3.80 |
Provisions made |
- |
- |
- |
- |
- |
Depreciation |
1.74 |
1.72 |
1.72 |
1.74 |
1.72 |
Taxation |
- |
- |
- |
- |
- |
Net profit / loss |
-3.33 |
-4.60 |
-3.61 |
-3.80 |
-4.73 |
Extra ordinary item |
- |
- |
- |
- |
- |
Prior year adjustments |
- |
- |
- |
- |
- |
Equity capital |
24.04 |
24.04 |
24.04 |
24.04 |
24.04 |
Equity dividend rate |
- |
- |
- |
- |
- |
Agg.of non-prom. shares (Lacs) |
74.85 |
74.85 |
74.85 |
74.85 |
74.85 |
Agg.of non promotoholding (%) |
31.14 |
31.14 |
31.14 |
31.14 |
31.14 |
OPM (%) |
- |
-124.81 |
-5.45 |
-6.22 |
-29.00 |
GPM (%) |
- |
-272.94 |
-35.96 |
-30.88 |
-61.09 |
NPM (%) |
- |
-435.98 |
-68.75 |
-57.06 |
-96.00 |